BackBioNTech SE Overview
BioNTech SE - ADR

BioNTech SE Target Price

Analysts' 12-month price predictions for BNTX.

Share Price

$104.4

Average Target Price

$125.2520% upside

4 analysts in the last 4 months

High: $145 | Low: $110

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2025-06-02Leerink PartnersDaina Graybosch$1127.3% upsideOpen
2025-05-29Goldman SachsAsad Haider$1105.4% upsideOpen
2025-05-14H.C. WainwrightRobert Burns$13428.4% upsideOpen
2025-04-01H.C. Wainwright$14538.9% upsideOpen
2024-11-19Evercore ISICory Kasimov$12519.7% upsideOpen
2024-11-13Leerink PartnersDaina Graybosch$12115.9% upsideOpen
2024-11-08Goldman SachsChris Shibutani$13731.2% upsideOpen
2024-11-04BMO CapitalEtzer Darout$12620.7% upsideOpen
2024-09-23Morgan StanleyTerence Flynn$14538.9% upsideOpen
2024-09-17JefferiesAkash Tewari$15043.7% upsideOpen
2024-09-16Bank of America SecuritiesTazeen Ahmad$15043.7% upsideOpen
2024-09-13JefferiesAkash Tewari$968% downsideOpen
2024-08-06Deutsche BankEmmanuel Papadakis$959% downsideOpen
2024-08-05Morgan StanleyTerence Flynn$9310.9% downsideOpen
2024-08-02HSBCYifeng Liu$1013.3% downsideOpen
2024-06-26H.C. WainwrightRaghuram Selvaraju$1138.2% upsideOpen
2024-05-13Evercore ISICory Kasimov$1004.2% downsideOpen
2024-05-07BMO CapitalEtzer Darout$12216.9% upsideOpen
2024-03-22HSBCYifeng Liu$9013.8% downsideOpen
2024-03-21Canaccord GenuityWilliam Maughan$17163.8% upsideOpen
2024-03-21BMO CapitalEtzer Darout$12317.8% upsideOpen
2024-03-21Goldman SachsChris Shibutani$9112.8% downsideOpen
2023-01-31Goldman Sachs$15649.4% upsideOpen
2022-12-02Leerink PartnersMani Foroohar$8122.4% downsideOpen
2022-05-17UBSAndrew Ang$16860.9% upsideOpen
2022-05-10Morgan StanleyMatthew Harrison$19586.8% upsideOpen
2022-04-16H.C. WainwrightRobert Burns$298185.4% upsideOpen
2022-04-10Canaccord GenuityArlinda Lee$300187.4% upsideOpen
2022-01-21UBSEliana Merle$17062.8% upsideOpen
2021-12-22Kempen & CoSuzanne van Voorthuizen$350235.2% upsideOpen
2021-12-09Leerink PartnersDaina Graybosch$253142.3% upsideOpen
2021-10-04Bryan Garnier & Co LtdOlga Smolentseva$359243.9% upsideOpen